No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / metabolism
-
Adenocarcinoma / secondary
-
Adult
-
Aged
-
Androgen Receptor Antagonists / therapeutic use*
-
Androstenes / therapeutic use
-
Anilides / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Bone Neoplasms / drug therapy*
-
Bone Neoplasms / metabolism
-
Bone Neoplasms / secondary
-
Cancer Vaccines / therapeutic use
-
Humans
-
Male
-
Nitriles / therapeutic use
-
Parotid Neoplasms / metabolism
-
Parotid Neoplasms / pathology*
-
Receptors, Androgen / metabolism*
-
Tosyl Compounds / therapeutic use
Substances
-
Androgen Receptor Antagonists
-
Androstenes
-
Anilides
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Cancer Vaccines
-
Nitriles
-
Receptors, Androgen
-
Tosyl Compounds
-
bicalutamide
-
pembrolizumab
-
abiraterone
-
IMM-101